Walgreens pharmacy in Los Angeles, Friday, March 10, 2023. (AP Photo/Jae C. Hong)
Walgreens, the major drugstore chain, is cutting its dividend by almost 50% in an effort to strengthen its financial position.
The company announced a reduction in its quarterly payout to shareholders to 25 cents per share, down from the 48 cents per share announced in October. The move is aimed at freeing up capital to support the growth of its pharmacy and healthcare businesses.
New CEO Tim Wentworth stated that the company believes such growth initiatives will ultimately enhance shareholder value. Analysts, including Edward Jones and John Boylan, view the dividend cut as a necessary step in the financial recovery process.
Despite the dividend reduction, Walgreens reported a better-than-expected fiscal first quarter, with sales growing 10% to $36.7 billion. The company is navigating challenges in the healthcare industry, including a drop in COVID-19 vaccines and testing, reimbursement issues, and pharmacy staffing shortages.
Walgreens is focused on cost-cutting measures and increasing cash flow while exploring strategic options to boost shareholder value. The company's fiscal year guidance remains unchanged, with expected earnings ranging between $3.20 and $3.50 per share.
However, challenges in the new fiscal year include lower contributions from COVID-19-related activities and a higher tax rate. The company's stock experienced a 7.2% decline to $23.74 in early trading following the dividend announcement.
